Why Two Alzheimer’s Blood Tests May Report Results Differently

See why amyloid and p-tau blood tests can conflict and which follow-up tests bring a clearer diagnosis.

Alzheimer's blood tests, which measure brain-related proteins to help explain memory symptoms, can differ because they test different proteins on different scales. They also use brand-specific cutoffs and respond differently to kidney function and metabolic conditions. That means two results from the same person can point in different directions. Doctors treat these blood tests as aids to diagnosis, alongside symptoms and exams, rather than as final answers by themselves.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What each test actually measures

Fujirebio's Lumipulse G measures the ratio of pTau217 to beta-amyloid 1-42 in plasma. C2N's PrecivityAD2 instead combines Aβ42/40 with percent p-tau217 by mass spectrometry into a 0-100 amyloid probability score, as C2N described via BusinessWire in its FDA clearance announcement. The numbers look similar on paper, but they are different analytes on different scales.

Roche's Elecsys pTau181 adds another split. According to the Duke-UNC Alzheimer's Disease Research Center, it measures a different tau site than pTau217 tests and is positioned as a primary-care rule-out test. Lumipulse is positioned for workup of symptomatic adults ages 55 and older, so a positive or negative from one use does not equal the same call from the other.

Why the same blood can pass one cutoff and fail another

There is no single p-tau217 number that fits every brand. Gemynd Publishing notes that different immunoassays use different antibodies and set their own cutoffs. The same sample can test positive on one kit and negative or borderline on another.

Many tests also use two cutoffs with a middle zone. Values above the high cutoff count as amyloid-positive and values below the low cutoff count as negative. Scores in between need confirmatory amyloid PET or spinal-fluid testing, as described in a Nature Medicine summary of two-cutoff testing.

How kidney and metabolic health shift blood markers

Even mild kidney dysfunction can raise several Alzheimer's blood markers. Vanderbilt University Medical Center reports that diabetes, high cholesterol, obesity, heart and vessel disease, and drugs that affect kidney clearance can also push Aβ42, p-tau181, and p-tau217 toward false positives or negatives, as detailed in Vanderbilt University Medical Center's report.

A Karolinska Institutet study, reported by Technology Networks, found diabetes and abnormal lipids altered amyloid markers apart from Alzheimer pathology. The same report found p-tau217 stayed more steady. That pattern helps explain why an amyloid-ratio test and a p-tau test can disagree in the same patient.

What to do when two results disagree

FDA-cleared blood tests are aids for adults with cognitive symptoms, not standalone screening checks. The Scientist notes that discordant results between brands should prompt clinical review and PET or spinal-fluid confirmation before treatment choices.

The Alzheimer's Association sets high accuracy goals for replacing PET or spinal-fluid tests. MLO Online, reporting the Association guidance, notes many commercial tests fall short, so clinical assessment plus confirmatory imaging remains needed for lower-performing tests. Ask your clinic which brand it uses, what its cutoffs and follow-up rules are, and whether your health history could have shifted the score.

  • Bring both lab reports, with brand names, reference ranges, and cutoff notes.
  • List kidney problems, diabetes, cholesterol, weight, heart disease, and current drugs.
  • Ask whether the result falls in an intermediate zone that needs PET or spinal-fluid follow-up.
  • Do not start, stop, or switch treatment based on one blood result alone.

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.